Genetic Analysis

Can Gene Therapy DB-OTO Revolutionize Treatment for Genetic Hearing Loss?
Tech & Innovation Can Gene Therapy DB-OTO Revolutionize Treatment for Genetic Hearing Loss?

In this interview, we are pleased to welcome Ivan Kairatov, a Biopharma expert with deep knowledge of tech and innovation in the industry and extensive experience in research and development, particularly in gene therapy for sensory disorders. Today, Ivan will share insights on the recent positive

How Do Environmental Factors Impact Human Aging and Premature Mortality?
Research & Development How Do Environmental Factors Impact Human Aging and Premature Mortality?

Human aging is a complex process influenced by a combination of genetic and environmental factors. While the role of genetics has been widely studied, recent research highlights the significant impact of environmental exposures on aging and premature mortality. This article delves into the findings

Personalized Medicine Revolutionizes Healthcare in Canada
Tech & Innovation Personalized Medicine Revolutionizes Healthcare in Canada

Ivan Kairatov is a Biopharma expert, with deep knowledge of tech and innovation in the industry and experience in research and development. Can you tell us a little about your professional background and your role as a biopharma expert? Certainly. I have spent the last couple of decades working at

Cancer Cells Cooperate to Secure Nutrients, Revealing New Treatment Targets
Research & Development Cancer Cells Cooperate to Secure Nutrients, Revealing New Treatment Targets

Cancer biology has traditionally emphasized the competitive nature of tumor cells as they compete fiercely for limited resources. However, recent research led by Carlos Carmona-Fontaine at New York University has unveiled a groundbreaking and surprising discovery that cancer cells also exhibit

Could SGT-003 Gene Therapy Be the Breakthrough for Duchenne Treatment?
Research & Development Could SGT-003 Gene Therapy Be the Breakthrough for Duchenne Treatment?

Duchenne muscular dystrophy (DMD) is a devastating genetic disorder that progressively deteriorates muscle function, posing a major challenge for patients and their families. Recently, a promising breakthrough has emerged in the form of Solid Biosciences' experimental gene therapy, SGT-003, which

Can an Osteoporosis Drug Unlock Treatment for Genetic Heart Disease?
Tech & Innovation Can an Osteoporosis Drug Unlock Treatment for Genetic Heart Disease?

In recent developments, a collaborative research team led by the University of Arizona College of Medicine – Tucson has discovered groundbreaking potential for an FDA-approved osteoporosis drug in the treatment of a rare genetic heart disease. The heart condition in question is dilated

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later